Suppression of vitamin D metabolizing enzyme CYP24A1 provides increased sensitivity to chemotherapeutic drugs in breast cancerSakura Kamiya(Sapporo Medical University), Makoto Osanai(Sapporo Medical University)bioRxiv (Cold Spring Harbor Laboratory)October 21, 202210.1101/2022.10.18.512762Cited by 2SaveCiteExport RISWatch citationsRelated PapersSuppression of the vitamin D metabolizing enzyme CYP24A1 provides increased sensitivity to chemotherapeutic drugs in breast cancer|Oncology Reports|2023|7